White paper

Generic Drugs: Market Access and Pricing in Europe

Generic Drugs: Market Access and Pricing in Europe

Author: Peter Wittner

The generics industry is an unpredictable environment that is constantly changing. It is probably quite realistic to also describe the generics business as a Darwinian world where companies need to evolve to survive. Those that do not evolve will be overtaken or eaten by more efficient competitors that do know how to evolve. The motto is 'Evolve or become extinct'! What if part of the survival strategy requires us to move from the comfort of our familiar home market into another national market as part of our expansion?

We hope you enjoy reading our white paper 'Generic Drugs: Market Access & Pricing in the EU'.






 

 

Download

White paper

Generic Drugs: Market Access and Pricing in Europe

Download

Download

I agree that the FORUM Institut may contact me to inform me about events and relevant content.
I can revoke my permission at any time.
Privacy Policy 
6 + 3 =   

Events “

Do filter
Sort
Tiles
Lists
Qualifikationslehrgang zum Market Access Manager

Das FORUM Institut für Management möchte Sie in Ihrer Fort- und Weiterbildung nachhaltig unterstützen. Aus diesem Grund bieten wir Ihnen neben unseren tradierten Intensivseminaren und Konferenzen einen modularen Qualifikationslehrgang im Bereich Market Access und Healthcare Management an. Er bietet Ihnen maßgeschneiderte Weiterbildung, genau auf Ihre Bedürfnisse abgestimmt.

Qualifikationslehrgang Einstieg jederzeit möglich
Generic Drugs: Market Access and Pricing in Europe

Success in generic drug market access and pricing in Europe - register now!

online 19/11/2024
e-Learning: Market Access for Medical Devices - The NUB Process

The e-learning provides a comprehensive understanding of the German healthcare system, market access and reimbursement of medical devices, with a particular focus on the NUB process. Get insider knowledge from our speaker and place your product successfully on the German market.

online